Cooley M&A

JANUARY 25, 2023

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Software Equity Group

JANUARY 22, 2024

A shift to patient-centered care A growing body of research and consumer demand are pushing healthcare organizations to adopt a more personalized, collaborative, comprehensive approach to caring for patients’ whole-health needs.

Healthcare 52

Healthcare M&A Valuation Medical 52

Software Equity Group

JANUARY 22, 2024

A shift to patient-centered care A growing body of research and consumer demand are pushing healthcare organizations to adopt a more personalized, collaborative, comprehensive approach to caring for patients’ whole-health needs.

Healthcare 52

Healthcare M&A Valuation Medical 52

Sun Acquisitions

AUGUST 22, 2024

Larger, consolidated companies can negotiate better terms with suppliers, secure more favorable contracts, and reduce per-unit production costs. By acquiring a supplier, businesses can ensure greater control over the supply chain, improving collaboration and communication.

M&A 52

M&A Management Mergers and Acquisitions Food 52

Devensoft

AUGUST 24, 2023

Unlike traditional external collaborations, where integration efforts may be outsourced or guided by external consultants, the internal integration model places the reins of control squarely within the capable hands of the organization itself. This blueprint serves as a roadmap for the entire integration journey.

Business 52

Business Collaboration Mergers and Acquisitions Management 52

Cooley M&A

JANUARY 21, 2022

Additionally, ESG initiatives – which Biden has promoted over the past year – may require navigation around antitrust issues regarding competitor collaborations. Congress targets pharmaceutical industry pricing and business practices. Indeed, the FTC has started inquiring about ESG practices in investigating mergers.

Mergers and Acquisitions 40

Mergers and Acquisitions Mergers Pharmaceutical IT 40